Condition: Acute Aortic Syndrome · Aortopathy · Sponsor: Nanjing Medical University
Acute Aortic Syndrome (AAS)/Aortic Aneurysm is a common feature of aortic wall events, including aortic dissection, intramural hematoma, aortic ulceration and aortic trauma, and occurs in up to 35 cases per 100,000 cases per year between the ages of 65 and 75 years. Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein predict cardiovascular events. Since statins lower levels of high-sensitivity C-reactive protein as well as cholesterol, the authors hypothesized that people with acute aortic syndrome but without hyperlipidemia might benefit from statin treatment.
This description comes directly from the study's public registry record.
Hong Liu, MD · 18801281613 · DR.HONGLIU@FOXMAIL.COM
Yong-feng SHAO, MD · 18801281613 · YFSHAOJPH@SINA.COM
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Recruiting |
| The first affiliated hospital of nanjing medical university | Nanjing, Jiangsu, China | Recruiting |
| Affiliated Hospital of Qingdao University | Qingdao, Shandong, China | Recruiting |
| West China Hospital of Sichuan University | Chengdu, Sichuan, China | Recruiting |
| Beijing Anzhen Hospital | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04699279